TcLand Expression is part of the Innovative Medicines Initiative “Be The CURE”, the largest European consortium for Rheumatology

TcLand Expression, a leading company focused on gene expression biomarkers in immunology and personalized medicine, today is pleased to announce its participation in the Innovative Medicines Initiative (IMI) project “Be The CURE”.EN.

TcLand Expression est heureux d’annoncer sa participation au projet “Be The Cure”, sélectionné dans le cadre du second appel à projet de l’IMI (Innovative Medicines Initiative).FR.

This entry was posted in R&D / Quality. Bookmark the permalink.

Comments are closed.